Comparison of accuracy of diabetes risk score and components of the metabolic syndrome in assessing risk of incident type 2 diabetes in Inter99 cohort

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Shafizadeh, Tracy B ^a   Moler, Edward J ^a   Kolberg, Janice A ^a   Nguyen, Uyen Thao ^a   Hansen, Torben ^b   Jorgensen, Torben ^c,d   Pedersen, Oluf ^b,d,e,f   Borch Johnsen, Knut ^e,g  

^a Tethys Bioscience   (United States)

^b HAGEDORN RESEARCH INSTITUTE   (Denmark)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e AARHUS UNIVERSITY   (Denmark)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

^g UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ACCURACY; ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; FALSE POSITIVE RESULT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; COMPARATIVE STUDY; MIDDLE AGED;

ADULT; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS;

EID: 79960920869     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022863     Document Type: Article

References (37)

1. Wild S, Roglic G, Green A, Sicree R, King H, (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053.
2. Mathers CD, Loncar D, (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3: e442.
3. CDC (2008) National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007 Atlanta.
4. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, et al. (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346: 393-403.
5. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, et al. (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344: 1343-1350.
6. de Vegt F, Dekker JM, Jager A, Hienkens E, Kostense PJ, et al. (2001) Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. JAMA 285: 2109-2113.
7. Gabir MM, Hanson RL, Dabelea D, Imperatore G, Roumain J, et al. (2000) The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 23: 1108-1112.
8. Nichols GA, Hillier TA, Brown JB, (2007) Progression from newly acquired impaired fasting glusose to type 2 diabetes. Diabetes Care 30: 228-233.
9. Shaw JE, Zimmet PZ, de Courten M, Dowse GK, Chitson P, et al. (1999) Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius? Diabetes Care 22: 399-402.
10. Vaccaro O, Ruffa G, Imperatore G, Iovino V, Rivellese AA, et al. (1999) Risk of diabetes in the new diagnostic category of impaired fasting glucose: a prospective analysis. Diabetes Care 22: 1490-1493.
11. Simmons RK, Alberti KG, Gale EA, Colagiuri S, Tuomilehto J, et al. (2010) The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia 53: 600-605.
12. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, et al. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120: 1640-1645.
13. Borch-Johnsen K, Wareham N, (2010) The rise and fall of the metabolic syndrome. Diabetologia 53: 597-599.
14. Kahn R, Buse J, Ferrannini E, Stern M, (2005) The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 48: 1684-1699.
15. Ford ES, Li C, Sattar N, (2008) Metabolic syndrome and incident diabetes: current state of the evidence. Diabetes Care 31: 1898-1904.
16. Stern MP, Williams K, Gonzalez-Villalpando C, Hunt KJ, Haffner SM, (2004) Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 27: 2676-2681.
17. Nichols GA, Moler EJ, (2010) Diabetes incidence for all possible combinations of metabolic syndrome components. Diabetes Res Clin Pract 90: 115-121.
18. Eddy DM, Schlessinger L, (2003) Archimedes: a trial-validated model of diabetes. Diabetes Care 26: 3093-3101.
19. Glumer C, Carstensen B, Sandbaek A, Lauritzen T, Jorgensen T, et al. (2004) A Danish diabetes risk score for targeted screening: the Inter99 study. Diabetes Care 27: 727-733.
20. Kahn HS, Cheng YJ, Thompson TJ, Imperatore G, Gregg EW, (2009) Two risk-scoring systems for predicting incident diabetes mellitus in U.S. adults age 45 to 64 years. Ann Intern Med 150: 741-751.
21. Kolberg JA, Jorgensen T, Gerwien RW, Hamren S, McKenna MP, et al. (2009) Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort. Diabetes Care 32: 1207-1212.
22. Lindstrom J, Tuomilehto J, (2003) The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 26: 725-731.
23. McNeely MJ, Boyko EJ, Leonetti DL, Kahn SE, Fujimoto WY, (2003) Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type 2 diabetes risk in Japanese Americans. Diabetes Care 26: 758-763.
24. Stern MP, Williams K, Haffner SM, (2002) Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med 136: 575-581.
25. Urdea M, Kolberg J, Wilber J, Gerwien R, Moler E, et al. (2009) Validation of a multimarker model for assessing risk of type 2 diabetes from a five-year prospective study of 6784 Danish people (Inter99). J Diabetes Sci Technol 3: 748-755.
26. Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM, et al. (2007) Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med 167: 1068-1074.
27. Salomaa V, Havulinna A, Saarela O, Zeller T, Jousilahti P, et al. (2010) Thirty-one novel biomarkers as predictors for clinically incident diabetes. PLoS one 5: e10100.
28. Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, et al. (2011) Metabolite profiles and the risk of developing diabetes. Nature Medicine 17: 448-453.
29. Jorgensen T, Borch-Johnsen K, Thomsen TF, Ibsen H, Glumer C, et al. (2003) A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. Eur J Cardiovasc Prev Rehabil 10: 377-386.
30. ADA (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33 (Suppl 1): S62-69.
31. ADA (2005) Diabetes 4-1-1; facts, figures, and statistics Alexandria, VA American Diabetes Association.
32. WHO (1999) Definition, Diagnosis and Classification of Daibetes Mellitus and Its Complications: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus Geneva World Health Organization.
33. (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106: 3143-3421.
34. Selvin E, Crainiceanu CM, Brancati FL, Coresh J, (2007) Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med 167: 1545-1551.
35. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM, (2003) The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 26: 3153-3159.
36. Grundy SM, (2006) Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 47: 1093-1100.
37. Ervin RB, (2009) Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. National health statistics reports pp. 1-7.